{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T09:48:30Z","timestamp":1782467310826,"version":"3.54.5"},"reference-count":51,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K10546"],"award-info":[{"award-number":["JP20K10546"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vaccine.2022.04.033","type":"journal-article","created":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T05:58:57Z","timestamp":1649656737000},"page":"3018-3026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6291-7186","authenticated-orcid":false,"given":"Masayoshi","family":"Shinjoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7742-1135","authenticated-orcid":false,"given":"Munehiro","family":"Furuichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1346-6729","authenticated-orcid":false,"given":"Hisato","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonori","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6335-360X","authenticated-orcid":false,"given":"Mizuki","family":"Yaginuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Nogayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-9352","authenticated-orcid":false,"given":"Michiko","family":"Chiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9923-7347","authenticated-orcid":false,"given":"Mio","family":"Oshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuu","family":"Kuramochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3122-2418","authenticated-orcid":false,"given":"Go","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-8104","authenticated-orcid":false,"given":"Atsushi","family":"Narabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4836-1732","authenticated-orcid":false,"given":"Ichiro","family":"Ookawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-3598","authenticated-orcid":false,"given":"Mitsuhiro","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Tsunematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isamu","family":"Kamimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoko","family":"Shimoyamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2846-2069","authenticated-orcid":false,"given":"Makoto","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimichi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Mitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9922-1775","authenticated-orcid":false,"given":"Takao","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2022.04.033_b0005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1086\/432938","article-title":"Mass vaccination of schoolchildren against influenza and its impact on the influenza-associated mortality rate among children in Japan","volume":"41","author":"Sugaya","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.04.033_b0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cid\/cir336","article-title":"Influenza vaccination of schoolchildren and influenza outbreaks in a school","volume":"53","author":"Kawai","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.04.033_b0015","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1586\/14760584.2014.951036","article-title":"A review of the indirect protection of younger children and the elderly through a mass influenza vaccination program in Japan","volume":"13","author":"Sugaya","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2022.04.033_b0020","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1016\/j.vaccine.2019.09.086","article-title":"Exploring indirect protection associated with influenza immunization - A systematic review of the literature","volume":"37","author":"Friedman","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7005a1","article-title":"Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021\u201322 Influenza Season","volume":"70","author":"Grohskopf","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2022.04.033_b0030","unstructured":"6. National Institute of Infectious Diseases. Figures for National Epidemiological Surveillance of Infectious Disease (NESVPD) (In Japanese), https:\/\/www.niid.go.jp\/niid\/ja\/y-graphs\/667-yosoku-graph.html; 2021 [accessed 20 September 2021]."},{"key":"10.1016\/j.vaccine.2022.04.033_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249005","article-title":"Influenza vaccine effectiveness against influenza A in children based on the results of various rapid influenza tests in the 2018\/19 season","volume":"16","author":"Shinjoh","year":"2021","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.04.033_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6908a1","article-title":"Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020\u201321 Influenza Season","volume":"69","author":"Grohskopf","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2022.04.033_b0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136539","article-title":"Effectiveness of trivalent inactivated influenza vaccine in children estimated by a test-negative case-control design study based on influenza rapid diagnostic test results","volume":"10","author":"Shinjoh","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.04.033_b0050","first-page":"21","article-title":"Trivalent inactivated influenza vaccine effective against influenza A(H3N2) variant viruses in children during the 2014\/15 season","author":"Sugaya","year":"2016","journal-title":"Japan Euro Surveill"},{"key":"10.1016\/j.vaccine.2022.04.033_b0055","doi-asserted-by":"crossref","first-page":"5510","DOI":"10.1016\/j.vaccine.2018.07.065","article-title":"Inactivated influenza vaccine effectiveness and an analysis of repeated vaccination for children during the 2016\/17 season","volume":"36","author":"Shinjoh","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0060","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.vaccine.2018.01.024","article-title":"Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013\u20132016","volume":"36","author":"Sugaya","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0065","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.vaccine.2019.05.090","article-title":"Effectiveness of inactivated influenza vaccine in children by vaccine dose, 2013\u201318","volume":"37","author":"Shinjoh","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiac.2021.08.020","article-title":"Risk factors in pediatric hospitalization for influenza A and B during the seven seasons immediately before the COVID-19 era in Japan","author":"Shinjoh","year":"2021","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2022.04.033_b0075","unstructured":"15. National Institute of Infectious Diseases. Information on epidemiology of influenza (In Japanese) https:\/\/www.niid.go.jp\/niid\/ja\/diseases\/a\/flu.html; 2020 [accessed 20 September 2021]."},{"key":"10.1016\/j.vaccine.2022.04.033_b0080","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jiac.2019.08.015","article-title":"Clinical evaluation of ID NOW influenza A & B 2, a rapid influenza virus detection kit using isothermal nucleic acid amplification technology - A comparison with currently available tests","volume":"26","author":"Mitamura","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2022.04.033_b0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jviromet.2013.08.018","article-title":"Clinical evaluation of highly sensitive silver amplification immunochromatography systems for rapid diagnosis of influenza","volume":"194","author":"Mitamura","year":"2013","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2022.04.033_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231217","article-title":"Very high sensitivity of a rapid influenza diagnostic test in adults and elderly individuals within 48 hours of the onset of illness","volume":"15","author":"Seki","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2022.04.033_b0095","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/infdis\/jiaa685","article-title":"Low influenza vaccine effectiveness against A(H3N2)-associated hospitalizations in 2016\u20132017 and 2017\u20132018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN)","volume":"223","author":"Martin","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.04.033_b0100","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/infdis\/jiaa800","article-title":"Influenza vaccine effectiveness against hospitalization in the United States, 2019\u20132020","volume":"224","author":"Tenforde","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.04.033_b0105","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.vaccine.2010.12.049","article-title":"The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons","volume":"29","author":"Katayose","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0110","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2020.12.012","article-title":"Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018","volume":"39","author":"Thangarajah","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0115","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/irv.12626","article-title":"Influenza B associated paediatric acute respiratory infection hospitalization in central Vietnam","volume":"13","author":"Yoshihara","year":"2019","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2022.04.033_b0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/cid\/cix312","article-title":"Population-based pediatric hospitalization burden of lineage-specific influenza B in Hong Kong, 2004\u20132014","volume":"65","author":"Cowling","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2022.04.033_b0125","first-page":"147","article-title":"Antibody response and protection after receipt of inactivated influenza vaccine: A systematic review","author":"Wall","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2022.04.033_b0130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/jamapediatrics.2020.0372","article-title":"Patterns of influenza vaccination and vaccine effectiveness among young US children who receive outpatient care for acute respiratory tract illness","volume":"174","author":"Chung","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2022.04.033_b0135","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00431-018-3145-7","article-title":"Effectiveness of inactivated quadrivalent influenza vaccine in the 2015\/2016 season as assessed in both a test-negative case-control study design and a traditional case-control study design","volume":"177","author":"Kimiya","year":"2018","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.vaccine.2022.04.033_b0140","doi-asserted-by":"crossref","unstructured":"Rose A, Kissling E, Emborg HD, Larrauri A, McMenamin J, Pozo F, et al. Interim 2019\/20 influenza vaccine effectiveness: six European studies, September 2019 to January 2020. Euro Surveill 2020; 25. https:\/\/doi.org10.2807\/1560-7917.Es.2020.25.10.2000153.","DOI":"10.2807\/1560-7917.ES.2020.25.10.2000153"},{"key":"10.1016\/j.vaccine.2022.04.033_b0145","doi-asserted-by":"crossref","unstructured":"Skowronski DM, Zou M, Sabaiduc S, Murti M, Olsha R, Dickinson JA, et al. Interim estimates of 2019\/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020. Euro Surveill 2020; 25. https:\/\/doi.org10.2807\/1560-7917.Es.2020.25.7.2000103.","DOI":"10.2807\/1560-7917.ES.2020.25.7.2000103"},{"key":"10.1016\/j.vaccine.2022.04.033_b0150","doi-asserted-by":"crossref","unstructured":"Skowronski DM, Leir S, Sabaiduc S, Murti M, Dickinson JA, Olsha R, et al. Interim estimates of 2018\/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Euro Surveill 2019; 24. https:\/\/doi.org10.2807\/1560-7917.Es.2019.24.4.1900055.","DOI":"10.2807\/1560-7917.ES.2019.24.4.1900055"},{"key":"10.1016\/j.vaccine.2022.04.033_b0155","unstructured":"National Institute of Infectious Diseases. Reactivity between isolated A(H1N1)pdm virus and antiserum in the 2019\/20 season in Japan (In Japanese) https:\/\/www.niid.go.jp\/niid\/images\/flu\/antigenic\/20201130\/1.jpg; 2020 [accessed 20 September 2021]."},{"key":"10.1016\/j.vaccine.2022.04.033_b0160","unstructured":"Yokohama City Institute of Public Health. Analysis of isolated influenza virus in Yokohama City in 2019\/20 season (In Japanese), 2020."},{"key":"10.1016\/j.vaccine.2022.04.033_b0165","unstructured":"National Institute of Infectious Diseases. Preliminary report of isolated virus, Infectious Agents Surveillance Report (IASR) (In Japanese), https:\/\/www.niid.go.jp\/niid\/ja\/typhi-m\/iasr-reference\/510-graphs\/1532-iasrgv.html; 2021 [accessed 20 September 2021]."},{"key":"10.1016\/j.vaccine.2022.04.033_b0170","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1016\/j.vaccine.2021.05.049","article-title":"The missing season: The impacts of the COVID-19 pandemic on influenza","volume":"39","author":"Zipfel","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0175","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1038\/s41467-021-23440-1","article-title":"Impact of COVID-19 outbreaks and interventions on influenza in China and the United States","volume":"12","author":"Feng","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2022.04.033_b0180","unstructured":"World Health Organization. South-East Asia Region of WHO. Influenza Laboratory Surveillance Information by the Global Influenza Surveillance and Response System (GISRS), https:\/\/apps.who.int\/flumart\/Default?ReportNo=3&WHORegion=; 2021 [accessed 20 September 2021]."},{"key":"10.1016\/j.vaccine.2022.04.033_b0185","unstructured":"World Health Organization. Southern hemisphere. Influenza Laboratory Surveillance Information by the Global Influenza Surveillance and Response System (GISRS), https:\/\/apps.who.int\/flumart\/Default?Hemisphere=Southern&ReportNo=5; 2021 [accessed 20 September 2021]."},{"key":"10.1016\/j.vaccine.2022.04.033_b0190","doi-asserted-by":"crossref","unstructured":"Weinberger Opek M, Yeshayahu Y, Glatman-Freedman A, Kaufman Z, Sorek N, Brosh-Nissimov T. Delayed respiratory syncytial virus epidemic in children after relaxation of COVID-19 physical distancing measures, Ashdod, Israel, 2021. Euro Surveill 2021; 26. https:\/\/doi.org10.2807\/1560-7917.Es.2021.26.29.2100706.","DOI":"10.2807\/1560-7917.ES.2021.26.29.2100706"},{"key":"10.1016\/j.vaccine.2022.04.033_b0195","article-title":"Resurgence of respiratory syncytial virus infections during COVID-19 pandemic, Tokyo","volume":"27","author":"Ujiie","year":"2021","journal-title":"Japan Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.04.033_b0200","article-title":"The flu vaccination may have a protective effect on the course of COVID-19 in the pediatric population: When does severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) meet influenza?","volume":"13","author":"Patwardhan","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.vaccine.2022.04.033_b0205","doi-asserted-by":"crossref","unstructured":"Kowalska M, Niewiadomska E, Bara\u0144ski K, Kaleta-Pilarska A, Bro\u017cek G, Zejda JE. Association between influenza vaccination and positive SARS-CoV-2 IgG and IgM tests in the general population of Katowice Region, Poland. Vaccines (Basel) 2021; 9. https:\/\/doi.org10.3390\/vaccines9050415.","DOI":"10.3390\/vaccines9050415"},{"key":"10.1016\/j.vaccine.2022.04.033_b0210","article-title":"Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ","author":"Fink","year":"2020","journal-title":"Evid Based Med"},{"key":"10.1016\/j.vaccine.2022.04.033_b0215","doi-asserted-by":"crossref","unstructured":"Horns F, Dekker CL, Quake SR. Memory B cell activation, broad anti-influenza antibodies, and bystander activation revealed by single-cell transcriptomics. Cell Rep 2020; 30:905-13.e6. https:\/\/doi.org10.1016\/j.celrep.2019.12.063.","DOI":"10.1016\/j.celrep.2019.12.063"},{"key":"10.1016\/j.vaccine.2022.04.033_b0220","doi-asserted-by":"crossref","first-page":"394","DOI":"10.7326\/M17-0848","article-title":"Diagnostic accuracy of novel and traditional rapid tests for influenza infection compared with reverse transcriptase polymerase chain reaction: A systematic review and meta-analysis","volume":"167","author":"Merckx","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2022.04.033_b0225","unstructured":"World Health Organization. WHO public health research agenda for influenza: Optimizing treatment of patients, 2017 update., https:\/\/apps.who.int\/iris\/handle\/10665\/259887; 2017 [accessed 20 September 2021]."},{"key":"10.1016\/j.vaccine.2022.04.033_b0230","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.vaccine.2015.01.069","article-title":"Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness","volume":"33","author":"Jackson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijid.2020.07.032","article-title":"Effectiveness of trivalent inactivated influenza vaccines in children during 2017\u20132018 season in Korea: Comparison of test-negative analysis by rapid and RT-PCR influenza tests","volume":"99","author":"Sohn","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.04.033_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2019.100011","article-title":"Effectiveness of the quadrivalent inactivated influenza vaccine in Japan during the 2015\u20132016 season: A test-negative case-control study comparing the results by real time PCR, virus isolation","volume":"1","author":"Chon","year":"2019","journal-title":"Vaccine X"},{"key":"10.1016\/j.vaccine.2022.04.033_b0245","doi-asserted-by":"crossref","unstructured":"Recommendations for prevention and control of influenza in children, 2020-2021. Pediatrics 2020; 146. https:\/\/doi.org10.1542\/peds.2020-024588.","DOI":"10.1542\/peds.2020-024588"},{"key":"10.1016\/j.vaccine.2022.04.033_b0250","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1016\/j.vaccine.2017.07.003","article-title":"Basic principles of test-negative design in evaluating influenza vaccine effectiveness","volume":"35","author":"Fukushima","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.04.033_b0255","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/infdis\/jiab273","article-title":"Modeling the impacts of clinical influenza testing on influenza vaccine effectiveness estimates","volume":"224","author":"Feldstein","year":"2021","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22004492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T07:37:56Z","timestamp":1718437076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22004492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":51,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0264410X22004492"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.033","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in effectiveness of inactivated influenza vaccine in children by age groups in seven seasons immediately before the COVID-19 era","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}